Melanoma
Melanoma
Advertisement
Dr. John Fruehauf, EvolentMelanoma | December 19, 2024
Dr. John Fruehauf provided an in-depth overview of treatments for metastatic melanoma.
View More
Jordana JampelMelanoma | December 18, 2024
The primary outcomes of the study were melanoma-related deaths and nonmelanoma-related deaths.
Jordana JampelMelanoma | December 4, 2024
TPC2 and Rab7a interaction may be responsible for melanoma proliferation.
Rob DillardMelanoma | November 21, 2024
Remote analysis of cancerous-looking skin growths yields the same level of accuracy as in-person analysis.
Jordana JampelMelanoma | November 18, 2024
Seventy-two percent of tumor specimens contained histologically defined LAs.
Jordana JampelMelanoma | November 11, 2024
The analysis included the CheckMate trials that involved ICI treatment-naive unresected/metastatic melanoma.
Dr. John Fruehauf, EvolentMelanoma | November 7, 2024
Dr. John Fruehauf, Evolent, talks about a new standard of care in the treatment of stage III melanoma. 
Jordana JampelHead and Neck Cancer | November 7, 2024
The combo's use for conjunctival melanoma demonstrates the combinations high efficacy in treating complex disease.
Rob DillardSkin Cancer | November 7, 2024
A novel method uses tumor-specific profiling to detect antibodies which are unique to early-stage melanoma.
Rob DillardMelanoma | November 7, 2024
The combination therapy of sotiga with pembrolizumab is effective at treating patients with metastatic melanoma.
Rob DillardSkin Cancer | November 7, 2024
Polygenic risk scores may serve as a viable tool to stratify patients based on their risk of invasive melanoma.
Rob DillardMelanoma | November 7, 2024
Several studies have uncovered how immunotherapies work in concert to improve outcomes in patients with melanoma.
Rob DillardSkin Cancer | November 7, 2024
A factor secreted by tumor cells is responsible for the resistance of melanoma to treatment.
Rob DillardASCO 2024 | November 7, 2024
One year of immunotherapy is optimal for treating patients with advanced melanoma.
Rob DillardASCO 2024 | November 7, 2024
Medicaid expansion and improved access to health care services facilitate diagnosing melanoma at an early stage.
Rob DillardMelanoma | November 7, 2024
Risk factors beyond sun exposure, including gene mutations, can influence a person's chances of developing melanoma.
Oncology BrothersOncology Brothers | November 7, 2024
Dr. Patel joins The Oncology Brothers to discuss in-depth how to treat cutaneous melanoma using a treatment algorithm.
Rob DillardADA 2023 | November 7, 2024
DPP-4 inhibitors, used to control blood sugar levels in adults with type 2 diabetes, may reduce the risk of melanoma.
Cailin ConnerSkin Cancer | November 7, 2024
Melanoma is the deadliest of skin cancers. It develops in cells that produce melanin (the pigment that gives skin its ...
Patrick DalySkin Cancer | November 7, 2024
In a recent article, published in the Journal of Cancer Research and Clinical Oncology, researchers examined the protein ...
Advertisement
Advertisement
Advertisement
Latest News

December 20, 2024